The cost of US healthcare is going up but outcomes are getting worse – the venture community is at the heart of the search for innovative solutions, says Luke Düster, chief investment officer at CRG
With US healthcare costs rising and patient outcomes declining, the search for innovative solutions has become urgent. In an exclusive interview, Luke Düster, Chief Investment Officer at CRG, discusses how the venture community is stepping up to meet these challenges. Düster highlights the critical role of venture capital in driving breakthroughs that could transform the healthcare landscape and deliver better results for patients.
For an in-depth look at Düster’s insights on navigating these pressing issues:
CRG’s Brian Englander sat down with Joe Catanese, CEO of Calyxo, to discuss the kidney stone market, his career, and how his team is working to change kidney stone treatment through its innovative technology, ultimately improving the quality of care for patients who suffer from kidney stones.